Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin [1]

Annals of Oncology

Volumn 14, Issue 11, 2003, Pages 1689-1690

  Carlini, P ^a   Di Cosimo, S ^a   Ferretti, G ^a   Papaldo, P ^a   Fabi, A ^a   Ruggeri, E M ^a   Milella, M ^a   Cognetti, F ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; ESTRADIOL; ESTRONE; FOLLITROPIN; GONADORELIN DERIVATIVE; HYDROCORTISONE; LETROZOLE; LIOTHYRONINE; LUTEINIZING HORMONE; MINOXIDIL; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TAMOXIFEN; TESTOSTERONE; THYROXINE; TRIPTORELIN;

ADULT; ALOPECIA; BLOOD SAMPLING; BREAST CANCER; CASE REPORT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GYNECOLOGICAL EXAMINATION; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; LETTER; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; ALOPECIA; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HORMONES; HUMANS; NITRILES; PREMENOPAUSE; TRIAZOLES; TRIPTORELIN;

EID: 0345688037     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg444     Document Type: Letter

References (5)

1. Dowsett M, Doody D, Miall S et al. Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer. Breast Cancer Res Treat 1999; 56: 25-34.
2. Niiyama S, Happle R, Hoffmann R. Influence of estrogens on the androgen metabolism in different subunits of human hair follicle. Eur J Dermatol 2001; 11: 195-198.
3. Sawaya ME, Price VH. Different levels of 5 α-reductase type I and II, aromatase and androgen receptor in hair follicles of women and men with androgenic alopecia. J Invest Dermatol 1997; 109: 296-300.
4. Gateley CA, Bundred NJ. Alopecia and breast disease. BMJ 1997; 314: 481.
5. Vexiau P, Chaspoux C, Boudou P et al. Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism. Arch Dermatol Res 2000; 292: 598-604.